Manning Meredith
- SEC CIK
- 0001752631
In the past year, 1 open-market sale filing worth $229.0K and no purchases.
Current role at each company
- SLNO Soleno Therapeutics IncChief Commercial Officeras of May 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $229.0K
- 1 filing
- Net
- −$229.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Manning Meredith as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 (view filing) | Mar 27 | 4 days | Manning MeredithChief Commercial Officer | SSale | −7.52K | $30.44 | −$229.0K | −10.4%64.5K after | 3 lots |
| Mar 31, 2025 (view filing) | Mar 27 | 4 days | Manning MeredithChief Commercial Officer | SSale | −45.2K | $67.28 | −$3.04M | −49.9%45.4K after | 9 lots |